Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

NCT04523727 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Interventions

DRUG: ferric citrate

Sponsor

Keryx Biopharmaceuticals